SCHEMBL6529683

SCHEMBL6529683

NC(CO)(CO)Cc1ccc(-c2ccccc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.49
RAB9A P51151 1/20 0.49
TAAR1 Q96RJ0 4/20 0.48
KDM4E B2RXH2 1/20 0.46
POLB P06746 1/20 0.46
S1PR1 P21453 2/20 0.45
S1PR3 Q99500 1/20 0.45
IDO1 P14902 2/20 0.44
AGXT P21549 2/20 0.44
ABCC4 O15439 1/20 0.44
LMNA P02545 1/20 0.44
GAA P10253 1/20 0.44
TSHR P16473 1/20 0.44
PTGS1 P23219 1/20 0.44
CYP3A4 P08684 1/20 0.43
HSD17B10 Q99714 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
HIF1A Q16665 1/20 0.42
SLC6A2 P23975 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6528202 0.96 HTT (0.50) HTTRAB9ATAAR1KDM4EPOLB
SCHEMBL2351133 0.87 KDM4E (0.57) TAAR1KDM4EPOLBLMNATSHR
Hydrochloric Acid SCHEMBL3889042 0.85 KDM4E (0.55) TAAR1KDM4EPOLBIDO1AGXT
SCHEMBL465335 0.83 KDM4E (0.57) TAAR1KDM4EPOLBLMNATSHR
Biphenyl-4-Amine SCHEMBL5586039 0.82 CYP3A4 (0.62) HTTRAB9ATAAR1KDM4EPOLB
SCHEMBL6529404 0.81 S1PR1 (0.59) HTTRAB9AS1PR1S1PR3FFAR1
SCHEMBL9539267 0.79 KDM4E (0.53) TAAR1KDM4EPOLBLMNATSHR
Felbinac SCHEMBL15067668 0.78 LMNA (0.72) HTTABCC4LMNAGAATSHR
SCHEMBL6505535 0.77 S1PR1 (0.55) S1PR1S1PR3FFAR1
SCHEMBL2211080 0.76 SLC6A2 (0.52) TAAR1KDM4EPOLBS1PR1S1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005014525-A2 BI-ARYL COMPOUND HAVING IMMUNOSUPPRESSIVE ACTIVITY MITSUBISHI PHARMA CORPORATION (JP) 2005-02-17 WO claimed